Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair
| Autor: | Michel Pellerin, Anique Ducharme, Francois Simon, Raoul Bonan, Arsène Basmadjian, Anita W. Asgar, Patrick Garceau, Denis Bouchard, Neila Sayah |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cardiac Catheterization
medicine.medical_specialty Demographics medicine.medical_treatment 030204 cardiovascular system & hematology Single Center 03 medical and health sciences 0302 clinical medicine Humans Medicine Radiology Nuclear Medicine and imaging Prospective Studies 030212 general & internal medicine Heart Valve Prosthesis Implantation Mitral valve repair Guide catheter business.industry MitraClip Mitral Valve Insufficiency General Medicine Surgery Treatment Outcome Dilator Mitral Valve Transcatheter mitral valve repair Cardiology and Cardiovascular Medicine business Echocardiography Transesophageal |
| Zdroj: | Catheterization and Cardiovascular Interventions. 97:1230-1234 |
| ISSN: | 1522-726X 1522-1946 |
| Popis: | Objectives The aim of this study is to describe the initial experience with versacross transseptal (TS) system for transseptal puncture for the transcatheter mitral valve repair using the MitraClip device. Background Transeptal puncture is a key step in transcatheter mitral valve repair (MVR) and the use of the VersaCross system comprised of a sheath, a dilator and a radiofrequency wire has not been previously described. Methods Prospective single center study of consecutive patients undergoing transcatheter mitral valve repair with the MitraClip device were included. Targeted TS puncture was performed under transesophageal echocardiographic (TEE) guidance. Baseline demographics, procedural characteristics, and major adverse procedural events were collected. Results Twenty-five consecutive patients underwent transseptal puncture using the VersaCross TS system. Transseptal puncture was successful in 100% of patients. The mean time for TS puncture was 3 3 ± 1.6 min with no major adverse procedural events. The mean time from insertion of the VersaCross system to insertion of the MitraClip guide catheter was 3.8 ± 3.0 minutes. Conclusion The VersaCross TS system was successful in all patients for MitraClip procedure with no adverse procedural events and may be associated with increased procedural efficiency. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text